ea0047oc3 | Spotlight on Neuroendocrine tumours | Theranostics2016
Roselt Peter
, Noonan Wayne
, Jeffery Charmaine
, Price Roger
, Hedt Amos
A new radiopharmaceutical using the somatostatin analogue octreotide has been developed for use in humans. SARTATE consists of the novel bifunctional chelator, MeCOSar, conjugated to (Tyr3)-octreotate. MeCOSar is a superior chelator for copper over a wide pH range and at room temperature, which allows for SARTATE to be used as an imaging/therapy pair when radiolabelled with copper-64 and copper-67.4Cu-SARTATE was produced by radiola...